Day: March 7, 2023

WAYNE, Pa., March 07, 2023 (GLOBE NEWSWIRE) — Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023, at 12:00 p.m. (ET). A live audio webcast of the conference presentation will be available on the investor section of the Teleflex website at teleflex.com. About Teleflex IncorporatedTeleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia,...

OSLO, Norway (7 March 2023) – Today, TGS hosts its 2023 Capital Markets Day. Please find attached the presentation materials for today’s event. The Capital Markets Day presentations will last from CET 1300 to approximately CET 1600 and will be streamed live at tgs.com.  The event will take place at Felix Konferansesenter, Bryggetorget 3, Oslo, Norway, and afterward, we invite attendees to join us for a reception. Please register for TGS Capital Markets Day by emailing investor@tgs.com or view on demand by copying and pasting this link into your browser: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20230307_1. About TGS TGS provides scientific data and intelligence to companies active in the energy sector. In addition to a global, extensive and diverse energy data library, TGS offers specialized services such as...

Melville, NY., March 07, 2023 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (Nasdaq: BRTX), a clinical stage company focused on the development of first-in-class cell-based therapies, today announced that it will participate at the Roth 35th Annual Conference being held from March 12 – 14 at The Ritz Carlton, Laguna Niguel in Dana Point, California. Lance Alstodt, President and CEO of the Company, will be available for one-on-ones at the conference and will also be available for outside appointments with the investment community. He will provide an update on the Company’s expanded pipeline and near-term catalysts of its ongoing Phase 2 clinical trial targeting chronic lumbar disc disease.  Further information on this conference can be found below: March 12-14...

VANCOUVER, British Columbia, March 07, 2023 (GLOBE NEWSWIRE) — Reflex Advanced Materials Corp. (CSE: RFLX), (OTCQB:RFLXF), (FSE:HF2) (“Reflex” or the “Company”) is pleased to announce that it has entered into a Material Processing Agreement (“MPA”) with American Energy Technologies Co. (“AETC”), which is based in Arlington Heights, Illinois. Under the terms of the agreement, AETC will conduct metallurgical testwork with the goal of creating a technical support data package for Reflex’s target customer base, US Federal agencies and qualification programs with hi-tech customers in the battery and battery storage business. Concentrate from the Ruby property, a past producing mine located in south-west Montana, will be used to conduct the following testwork:Characterization of key physicochemical properties of concentrate from Ruby; Attempted...

Coherent will also demonstrate its 800G co-packaged multimode optical engine. PITTSBURGH, March 07, 2023 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a leader in optical communications components and subsystems, today announced that it will demonstrate an optical transceiver module operating at 200 Gbps per optical lane and co-packaged optical (CPO) multimode optical engine operating at 50 Gbps NRZ at OFC 2023 in San Diego, March 7-9, booth #3815. These pluggable and co-packaged modules embody the next generation of 800 Gbps and 1.6 Tbps optical modules for the data networking industry in single-mode and multimode applications, respectively. “These demonstrations will showcase the state of the art in datacom transceiver technology as we approach the era of terabit transmission,” said Dr. Lee Xu, Executive Vice President, Datacom...

MELBOURNE, Australia, March 07, 2023 (GLOBE NEWSWIRE) — Opthea Limited (ASX:OPT; Nasdaq:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that it has received an A$8.7 million (US$6.3 million) research and development (R&D) tax credit from the Australian Taxation Office. The cash incentive is for research and development costs incurred in the 2021/2022 financial year, and represents the amount disclosed in the company’s audited financial statements at 30 June 2022. The R&D tax incentive credit relates to both Australian and eligible overseas expenditure for the development of Opthea’s lead candidate OPT-302. The R&D Tax Incentive is as an Australian Federal Government program under which companies can receive cash...